In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
We are very excited to launch our new website! Please take a few moments to click around and explore...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...